2m 2m 2m 2m 2m 2m 2m
Neutra (NTRR)
OTC
$0.0002-$0.00005 (-25.00%)
Price as of Jun 23, 2026- $437,684.00Market Cap
- 50.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Neutra (NTRR)
$0.0002-$0.00005 (-25.00%)
NTRR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | -$0.00005 (-25.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 305,350 | ||
30-Day Average Volume | 1,051,598 | ||
1-Week Change | 50.00% | ||
1-Month Change | 0.00% | ||
1-Year Change | 50.00% | ||
3-Year Change | -75.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 2.9B | ||
Total Assets | $26,944.00 | ||
Market Cap | $437,684.00 | ||
Enterprise Value | $491,148.00 | ||
Period: QTR TTM FY | |||
Revenue | $1,311.00 | ||
Net Income | -$54,986.00 | ||
Free Cash Flow | -$442.00 | ||
EBIT | -$52,728.00 | ||
EBITDA | -$43,677.00 | ||
Net Working Capital | -$889,428.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 375 | ||
P/B | -0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -990 | ||
Price/Operating Cash Flow | -990 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 10/06/2015 | ||